BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
27.09
+1.21 (4.68%)
At close: Nov 8, 2024, 4:00 PM
27.39
+0.30 (1.10%)
After-hours: Nov 8, 2024, 5:31 PM EST

BridgeBio Pharma Stock Forecast

Stock Price Forecast

The 12 analysts with 12-month price forecasts for BridgeBio Pharma stock have an average target of 46.83, with a low estimate of 37 and a high estimate of 70. The average target predicts an increase of 72.87% from the current stock price of 27.09.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $37 $46.83 $46 $70
Change +36.58% +72.87% +69.80% +158.40%

Analyst Ratings

The average analyst rating for BBIO stock from 13 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jun '24Jul '24Aug '24Sep '24Oct '24Nov '24
Strong Buy 665555
Buy 443466
Hold 221122
Sell 000000
Strong Sell 000000
Total 12129101313

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$43
Strong Buy Reiterates $43 +58.73% Oct 25, 2024
Leerink Partners
Leerink Partners
Buy
Maintains
$47$46
Buy Maintains $47$46 +69.80% Oct 17, 2024
Scotiabank
Scotiabank
Buy
Initiates
$44
Buy Initiates $44 +62.42% Oct 16, 2024
Oppenheimer
Oppenheimer
Hold
Initiates
n/a
Hold Initiates n/a n/a Oct 3, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$43
Strong Buy Reiterates $43 +58.73% Oct 2, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
352.62M
from 9.30M
Increased by 3,690.39%
Revenue Next Year
214.17M
from 352.62M
Decreased by -39.26%
EPS This Year
-1.96
from -3.95
EPS Next Year
-3.13
from -1.96
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
40.56M8.25M69.72M77.65M9.30M352.62M214.17M504.12M
Revenue Growth
--79.66%745.14%11.38%-88.02%3,690.39%-39.26%135.38%
EPS
-2.48-3.80-3.90-3.26-3.95-1.96-3.13-2.30
EPS Growth
--------
Forward PE
--------
No. Analysts -----201915
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 957.9M 661.5M 773.9M
Avg 352.6M 214.2M 504.1M
Low 206.9M 43.1M 218.5M

Revenue Growth

Revenue Growth 20242025202620272028
High
10,196.6%
87.6%
261.3%
Avg
3,690.4%
-39.3%
135.4%
Low
2,124.0%
-87.8%
2.0%

EPS Forecast

EPS 20242025202620272028
High 2.85 -0.84 -0.54
Avg -1.96 -3.13 -2.30
Low -3.37 -4.86 -3.63

EPS Growth

EPS Growth 20242025202620272028
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.